Luteolin alleviates post-infarction cardiac dysfunction by up-regulating autophagy through Mst1 inhibition

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 1, 2016, Pages 147-156

  Hu, Jianqiang ^a   Man, Wanrong ^a   Shen, Min ^a   Zhang, Mingming ^a   Lin, Jie ^a   Wang, Tingting ^a   Duan, Yu ^a   Li, Congye ^a   Zhang, Rongqing ^a   Gao, Erhe ^b   Wang, Haichang ^a   Sun, Dongdong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autophagy; Luteolin; Mammalian Ste20 like kinase 1; Myocardial infarction

Indexed keywords

ADENOSINE TRIPHOSPHATE; CITRATE SYNTHASE; CREATINE KINASE MB; INTERLEUKIN 1ALPHA; LACTATE DEHYDROGENASE; LUTEOLIN; MAMMALIAN STERILE 20 LIKE KINASE 1; MULTIENZYME COMPLEX; PROTEIN P62; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; PROTEIN SERINE THREONINE KINASE; STK4 PROTEIN, MOUSE;

AGGRESOME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HYPOXIA; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; CELL CULTURE; CELL HYPOXIA; DRUG EFFECTS; GENETICS; HEART STROKE VOLUME; KNOCKOUT MOUSE; METABOLISM; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PRECLINICAL STUDY; RAT; UPREGULATION;

ANIMALS; APOPTOSIS; AUTOPHAGY; CARDIOTONIC AGENTS; CELL HYPOXIA; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; LUTEOLIN; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PROTEIN-SERINE-THREONINE KINASES; RATS; STROKE VOLUME; UP-REGULATION;

EID: 84956577933     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12714     Document Type: Article

References (37)

1. He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Med. 2005; 353: 1124-34.
2. Velazquez EJ, Pfeffer MA. Acute heart failure complicating acute coronary syndromes: a deadly intersection. Circulation. 2004; 109: 440-2.
3. Mehta SR, Cannon CP, Fox KA, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA. 2005; 293: 2908-17.
4. Velagaleti RS, Pencina MJ, Murabito JM, et al. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation. 2008; 118: 2057-62.
5. Roe MT, Messenger JC, Weintraub WS, et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol. 2010; 56: 254-63.
6. Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010; 362: 2155-65.
7. Chen J, Normand SL, Wang Y, et al. Recent declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries: progress and continuing challenges. Circulation. 2010; 121: 1322-8.
8. Cao F, Sun D, Li C, et al. Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. Eur Heart J. 2009; 30: 1986-94.
9. Lopez-Lazaro M. Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem. 2009; 9: 31-59.
10. Qian LB, Wang HP, Chen Y, et al. Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress. Pharmacol Res. 2010; 61: 281-7.
11. Wang G, Li W, Lu X, et al. Luteolin ameliorates cardiac failure in type I diabetic cardiomyopathy. J Diabetes Complications. 2012; 26: 259-65.
12. Middleton E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000; 52: 673-751.
13. Sun D, Huang J, Zhang Z, et al. Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS ONE. 2012; 7: e33491.
14. Qi L, Pan H, Li D, et al. Luteolin improves contractile function and attenuates apoptosis following ischemia-reperfusion in adult rat cardiomyocytes. Eur J Pharmacol. 2011; 668: 201-7.
15. Gustafsson AB, Gottlieb RA. Autophagy in ischemic heart disease. Circ Res. 2009; 104: 150-8.
16. Takemura G, Miyata S, Kawase Y, et al. Autophagic degeneration and death of cardiomyocytes in heart failure. Autophagy. 2006; 2: 212-4.
17. Yan L, Vatner DE, Kim SJ, et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA. 2005; 102: 13807-12.
18. Yamamoto S, Yang G, Zablocki D, et al. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J Clin Invest. 2003; 111: 1463-74.
19. Odashima M, Usui S, Takagi H, et al. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction. Circ Res. 2007; 100: 1344-52.
20. Xu J, Wang H, Lu X, et al. Posttraumatic administration of luteolin protects mice from traumatic brain injury: implication of autophagy and inflammation. Brain Res. 2014; 1582: 237-46.
21. Gao E, Lei YH, Shang X, et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res. 2010; 107: 1445-53.
22. Wu X, Xu T, Li D, et al. ERK/PP1a/PLB/SERCA2a and JNK pathways are involved in luteolin-mediated protection of rat hearts and cardiomyocytes following ischemia/reperfusion. PLoS ONE. 2013; 8: e82957.
23. Maejima Y, Kyoi S, Zhai P, et al. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat Med. 2013; 19: 1478-88.
24. Sun D, Li S, Wu H, et al. Oncostatin M (OSM) protects against cardiac ischaemia/reperfusion injury in diabetic mice by regulating apoptosis, mitochondrial biogenesis and insulin sensitivity. J Cell Mol Med. 2015; 19: 1296-307.
25. Sciarretta S, Zhai P, Shao D, et al. Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation. 2012; 125: 1134-46.
26. Weir RA, McMurray JJ, Velazquez EJ. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. Am J Cardiol. 2006; 97: 13F-25F.
27. Steg PG, Dabbous OH, Feldman LJ, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation. 2004; 109: 494-9.
28. Goldberg RJ, Spencer FA, Yarzebski J, et al. A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). Am J Cardiol. 2004; 94: 1373-8.
29. Lal H, Ahmad F, Zhou J, et al. Cardiac fibroblast glycogen synthase kinase-3beta regulates ventricular remodeling and dysfunction in ischemic heart. Circulation. 2014; 130: 419-30.
30. Nakai A, Yamaguchi O, Takeda T, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med. 2007; 13: 619-24.
31. Shih H, Lee B, Lee RJ, et al. The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol. 2011; 57: 9-17.
32. Verschooten L, Barrette K, Van Kelst S, et al. Autophagy inhibitor chloroquine enhanced the cell death inducing effect of the flavonoid luteolin in metastatic squamous cell carcinoma cells. PLoS ONE. 2012; 7: e48264.
33. Stotland A, Gottlieb RA. Mitochondrial quality control: easy come, easy go. Biochim Biophys Acta. 2015; 1853(10 Pt B). 2802-11.
34. Saito T, Sadoshima J. Molecular mechanisms of mitochondrial autophagy/mitophagy in the heart. Circ Res. 2015; 116: 1477-90.
35. Murphy E, Steenbergen C. Preconditioning: the mitochondrial connection. Annu Rev Physiol. 2007; 69: 51-67.
36. Liesa M, Shirihai OS. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 2013; 17: 491-506.
37. Del Re DP, Matsuda T, Zhai P, et al. Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice. J Clin Invest. 2010; 120: 3555-67.